MENLO PARK, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the following investor conferences:
- Stifel 2017 Healthcare Conference in New York at 4:15 p.m. ET on Tuesday, November 14, 2017.
- Piper Jaffray 29th Annual Healthcare Conference in New York at 3:30 p.m. ET on Tuesday, November 28, 2017.
A live audio webcast of each presentation will be available through the Investors section of Geron’s website (www.geron.com) under Events. Following the live presentations, the webcasts will be archived and available for replay for a period of 30 days.
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations